Clinical Trials for Raynaud's phenomenon - Leukemia and Raynaud's Phenomenon Clinical Trials

Clinical Trials for Raynaud's phenomenon
Wrongdiagnosis.com

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

* Phase I: Usually designed to evaluate safety, determine a safe dosage
range, and identify side effects on a small group of patients.
* Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
* Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
* Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Raynaud's phenomenon is grouped into the following categories:-

By Trial name:

The format for each of the following is:

* The name of the trial,
* followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
* followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Raynaud's phenomenon:

* Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon - This study is no longer recruiting patients (Current: 23 Nov 2006) - topical organogel with nitroglycerin
* Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon - This study is currently recruiting patients (Current: 23 Nov 2006) - MQX-503
* Lab Study of MQX-503 in Treatment of Raynaud's - This study is no longer recruiting patients (Current: 23 Nov 2006) - topical organogel with nitroglycerin
* Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006) - iloprost
* Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynauds Phenomenon - This study is no longer recruiting patients (Current: 23 Nov 2006) - Ginkgo biloba extract EGb 761®
* Raynaud's Treatment Study (RTS) - This study has been completed (Current: 23 Nov 2006) - nifedipine
* Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon - This study has been completed (Current: 23 Nov 2006) - Pletal
* Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon - This study has been completed (Current: 23 Nov 2006) - Pletal
* St. John's Wort in the Treatment of Raynaud's Phenomenon. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - St. John's Wort

By Drugs used:

The format for each of the following is:

* The drug,
* followed by the name of the trial,
* followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Raynaud's phenomenon:

* Ginkgo biloba extract EGb 761® - Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynauds Phenomenon - This study is no longer recruiting patients (Current: 23 Nov 2006)
* Iloprost - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis - This study has been completed (Current: 23 Nov 2006)
* MQX-503 - Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon - This study is currently recruiting patients (Current: 23 Nov 2006)
* Nifedipine - Raynaud's Treatment Study (RTS) - This study has been completed (Current: 23 Nov 2006)
* Pletal - Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon - This study has been completed (Current: 23 Nov 2006)
* Pletal - Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon - This study has been completed (Current: 23 Nov 2006)
* St. John's Wort - St. John's Wort in the Treatment of Raynaud's Phenomenon. - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
* Topical Organogel With Nitroglycerin - Lab Study of MQX-503 in Treatment of Raynaud's - This study is no longer recruiting patients (Current: 23 Nov 2006)
* Topical Organogel With Nitroglycerin - Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon - This study is no longer recruiting patients (Current: 23 Nov 2006)

The trial data on this page has been sourced from

* The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs.

Copyright © 2009 Health Grades Inc.